* These authors contributed equally
With the rapid advancement of laparoscopic techniques, the minimally invasive benefits of laparoscopic splenectomy combined with pericardial devascularization have become increasingly evident. In this context, we present a protocol for performing laparoscopic splenectomy alongside pericardial devascularization to treat hypersplenism and esophageal variceal hemorrhage resulting from portal hypertension.
Hypersplenism and esophageal variceal hemorrhage caused by portal hypertension are common and serious complications of decompensated cirrhosis. In recent years, with the widespread application of various therapeutic methods such as drugs, endoscopy, splenic artery embolization, transjugular intrahepatic portal shunt, and liver transplantation, the role of surgery in the treatment of portal hypertension has gradually diminished, and the indications for surgical treatment have become more strictly defined. However, according to the clinical practice in China, surgical treatment of portal hypertension still holds an important role that other treatments cannot fully replace. In fact, surgical treatment of portal hypertension is widely performed in hospitals at all levels in China, saving numerous lives. Splenectomy combined with pericardial devascularization (SPD) is the most common surgical method for treating hypersplenism and esophageal variceal hemorrhage caused by portal hypertension. Long-term clinical practice has proven that SPD is a safe and effective treatment for hypersplenism and esophageal variceal rupture and hemorrhage due to portal hypertension. With the rapid development of laparoscopic techniques, the minimally invasive advantages of laparoscopic splenectomy combined with pericardial devascularization (LSPD) have become increasingly evident. However, the successful performance of LSPD mainly depends on the skill and proficiency of the surgeon. In this context, this article presents detailed techniques for LSPD.
China has a high number of hepatitis cases, and hepatitis patients often develop cirrhosis1. Portal hypertension is a common complication of liver cirrhosis2,3. The common clinical manifestations include splenomegaly, hypersplenism, peritoneal effusion, portal-systemic collateral circulation, and portal hypertensive gastroenteropathy3,4,5. The rupture and hemorrhage of esophageal and gastric varices is the most critical complication and the leading cause of death in decompensated cirrhosis6,7,8.
In recent years, with the widespread use of various therapeutic methods such as drugs, endoscopy, splenic artery embolization, transjugular intrahepatic portal shunt, and liver transplantation, the role of surgery in treating portal hypertension has gradually diminished, and the indications for surgical treatment have been more strictly limited6,9,10,11,12,13. However, the long-standing use of surgical treatment for portal hypertension, particularly splenectomy combined with pericardial devascularization (SPD), has saved numerous lives and continues to play an indispensable role in China14,15. Long-term surgical practice has shown that SPD is safe and effective, with a low incidence of rebleeding and hepatic encephalopathy6,9,14,15,16.
With the popularization of minimally invasive surgery and advancements in laparoscopic techniques, laparoscopic splenectomy combined with pericardial devascularization (LSPD) has already been applied in clinical practice17,18,19,20,21. However, LSPD places higher demands on the technical proficiency of the surgeon. Given this, the present article provides detailed techniques for LSPD in treating hypersplenism and esophageal variceal hemorrhage caused by portal hypertension.
A total of 8 patients who underwent LSPD between October 2012 and September 2022 were included in this study. The operations were approved by the institutional review board of The First Affiliated Hospital of Jinan University. All patients provided written informed consent. The consumables and equipment required for the study are listed in the Table of Materials.
1. Inclusion criteria
2. Exclusion criteria
3. Preoperative preparation
4. Surgical technique
5. Postoperative procedures
A total of 8 patients (mean age: 50.75 years ± 6.43 years), including 6 males (75.0%) and 2 females (25.0%), were included. The cause of portal hypertension in all eight patients with cirrhosis was viral hepatitis. There were 5 patients (62.5%) with liver function classified as Child-Pugh grade A and 3 patients (37.5%) with Child-Pugh grade B. The mean major axis of the spleen for the patients was 196.50 mm ± 12.39 mm. The mean counts of white blood cells, hemoglobin, and platelets were (3.33 ± 0.81) × 109/L, 79.38 ± 10.85 g/L, and (48.13 ± 10.37) × 109/L, respectively (Table 1).
All the patients successfully underwent LSPD without conversion to open surgery. The mean operation time was 215.63 min ± 50.19 min, with a mean intraoperative blood loss of 128.75 mL ± 44.22 mL. The mean postoperative drainage time was 5.50 ± 0.76 days, and the mean postoperative hospital stay was 6.50 ± 0.76 days. The postoperative complication rate was 25.0%, including 1 case of pulmonary infection and 1 case of ascites (Table 2).
Figure 1: The trocar arrangement. Please click here to view a larger version of this figure.
Figure 2: Splenic artery ligation. (A) The left gastroepiploic vessels. (B) The short gastric vessels. (C) The pancreas and the splenic artery. (D) The splenic artery. Please click here to view a larger version of this figure.
Figure 3: Splenectomy. (A) The splenocolic ligament. (B) The splenorenal ligament. (C) The splenophrenic ligament. (D) The splenic pedicle. Please click here to view a larger version of this figure.
Figure 4: Pericardial devascularization. (A) The left gastric vessels. (B) The posterior gastric vessels. (C) The gastric branch of the coronary vein. (D) The inferior phrenic vessels. (E) esophageal branch of the coronary vein. (F) The esophageal branch of the coronary vein. Please click here to view a larger version of this figure.
Figure 5: Specimen removal and surgery completion. (A) Careful examination for remaining varicose vessels around the cardia. (B) The resected spleen is loaded into a specimen bag. (C) The surgical field is flushed using sterile saline. (D) A drainage tube is placed under the left diaphragm. Please click here to view a larger version of this figure.
Sex (n) | |
Male | 6 (75.0%) |
Female | 2 (25.0%) |
Age (years) | 50.75 ± 6.43 |
Etiology (n) | |
Viral hepatitis | 8 (100.0%) |
Alcoholic liver disease | 0 (0.0%) |
Non-alcoholic fatty liver disease | 0 (0.0%) |
Cholestasis | 0 (0.0%) |
Drug or toxin | 0 (0.0%) |
Child-Pugh grade (n) | |
A | 5 (62.5%) |
B | 3 (37.5%) |
Major axis of spleen (mm) | 196.50 ± 12.39 |
WBC (× 109/L) | 3.33 ± 0.81 |
HGB (g/L) | 79.38 ± 10.85 |
PLT (× 109/L) | 48.13 ± 10.37 |
Table 1: Clinical features of the patients. WBC = white blood cell; HGB = hemoglobin; PLT = platelet.
Operation time (minutes) | 215.63 ± 50.19 |
Intraoperative blood loss (mL) | 128.75 ± 44.22 |
Postoperative drainage time (days) | 5.50 ± 0.76 |
Postoperative hospital stay (days) | 6.50 ± 0.76 |
Postoperative complications (n) | 2 (25.0%) |
Incision infection | 0 (0.0%) |
Pulmonary infection | 1 (12.5%) |
Abdominal infection | 0 (0.0%) |
Postoperative bleeding | 0 (0.0%) |
Ascites | 1 (12.5%) |
Pancreatic leakage | 0 (0.0%) |
Portal thrombosis | 0 (0.0%) |
Table 2: Surgical outcomes of the patients.
A large proportion of people in China suffer from chronic hepatitis, which is an important factor leading to liver cirrhosis1,2. Patients with advanced liver cirrhosis often experience portal hypertension, resulting in a series of complications, such as splenomegaly, hypersplenism, peritoneal effusion, portal-systemic collateral circulation, and portal hypertensive gastroenteropathy3,4,5. Among these, the rupture and hemorrhage of esophageal and gastric varices is the most critical complication and the leading cause of death in decompensated cirrhosis6,7,8. According to previous literature reports, the mortality rate for the first bleeding episode is about 20%12,22. Additionally, the rate of variceal rebleeding is nearly 60%, with a mortality rate of 30%23.
In recent years, various therapeutic methods such as drugs, endoscopy, splenic artery embolization, transjugular intrahepatic portal shunt, and liver transplantation have been increasingly used in the treatment of portal hypertension6,9,10,11,12,13. Due to the unbalanced development of medical institutions at all levels in China, splenectomy combined with pericardial devascularization (SPD) still plays an indispensable role in treating hypersplenism and esophageal variceal hemorrhage caused by portal hypertension14,15. Hassab first proposed SPD for the treatment of portal hypertension in 196624. SPD relieves the excessive destruction of blood cells by removing the hyperfunctional spleen and corrects clinical manifestations such as thrombocytopenia, anemia, and granulocytopenia. Meanwhile, SPD can control bleeding by blocking abnormal blood flow between the portal vein and the azygos vein. After more than half a century of clinical practice, SPD has proven to have advantages such as high safety, a definitive hemostatic effect, low risk of rebleeding, and a low incidence of hepatic encephalopathy6,9,14,15,16.
Traditional open surgery involves larger trauma, greater intraoperative blood loss, longer postoperative recovery times, and a higher likelihood of complications such as ascites and portal vein thrombosis, which no longer meet the demand for minimally invasive procedures and fast recovery. The first laparoscopic splenectomy was reported in 1991 by Delaitre et al.25. However, there are only a limited number of studies on laparoscopic splenectomy combined with pericardial devascularization (LSPD) for the treatment of portal hypertension 17,18,19,20,21. LSPD places higher demands on the technical proficiency of the surgeon, which presents certain limitations to the development of this technique. In light of this situation, the present article provides detailed techniques for LSPD in treating hypersplenism and esophageal variceal hemorrhage caused by portal hypertension.
In the present cases, we included patients with splenomegaly and hypersplenism caused by portal hypertension. All the patients had a history of upper gastrointestinal hemorrhage and a poor response to conservative treatment. Preventive surgery remains controversial; it is generally not recommended for patients with no history of gastrointestinal hemorrhage. The relevant disputes need to be resolved through further prospective studies to provide more evidence.
There are several surgical approaches for splenectomy; we recommend ligation of the splenic artery as a priority. The position of the splenic artery is relatively fixed, making it easy to dissect and ligate the artery at the upper margin of the pancreas without excessive tissue separation that could result in bleeding. After ligating the main splenic artery, the spleen shrinks, increasing the operating space, which facilitates lifting the spleen. Additionally, prioritizing treatment of the main splenic artery can help avoid variceal vein rupture and hemorrhage that may affect the surgical field during the dissection of secondary splenic pedicle vessels, significantly reducing the incidence of conversion and ensuring the safety of the surgery.
Care should be taken to protect the tail of the pancreas, located near the splenic pedicle, when dissecting the perisplenic ligaments to avoid pancreatic injury and reduce the risk of postoperative pancreatic leakage complications.
When dealing with variceal blood vessels, they should be separated close to the stomach wall while avoiding rough pulling that could lead to variceal vein tearing and bleeding. If massive bleeding occurs during the operation, autologous blood transfusion can be considered if conditions permit. For the lower esophagus, it is important to ensure a dissociation length of at least 6 cm to expose and ligate any abnormal upper esophageal branches of the coronary vein. The platelet count should be monitored regularly after surgery, and antiplatelet drugs should be administered judiciously based on the specific situation.
This study presents detailed techniques for laparoscopic splenectomy combined with pericardial devascularization (LSPD) for hypersplenism and esophageal variceal hemorrhage caused by portal hypertension. Based on our experience, LSPD can be preliminarily considered feasible and safe for treating portal hypertension. However, due to the small number of cases in this study, more clinical research is needed to confirm these findings. Once further clinical studies validate its safety and efficacy, LSPD is expected to be more widely used in the future. It is recommended that LSPD be performed selectively by experienced surgeons.
The authors have nothing to disclose.
This work was supported by grants from the Science and Technology Planning Project of Guangzhou (No. 2023A04J1917), and the Medical Joint Fund of Jinan University (No. YXZY2024018).
Name | Company | Catalog Number | Comments |
10-mm trocar | Xiamen Surgaid Medical Device Co., LTD | NGCS 100-1-10 | Sterile, ethylene oxide sterilized, disposable |
12-mm trocar | Xiamen Surgaid Medical Device Co., LTD | NGCS 100-1-12 | Sterile, ethylene oxide sterilized, disposable |
5-mm trocar | Xiamen Surgaid Medical Device Co., LTD | NGCS 100-1-5 | Sterile, ethylene oxide sterilized, disposable |
Hem-o-lok | America Teleflex Medical Technology Co., LTD | 544240 | Sterile, ethylene oxide sterilized, disposable |
Linear stapling device | America Ethicon Medical Technology Co., LTD | PSEE60A | Sterile, ethylene oxide sterilized, disposable |
Pneumoperitoneum needle | Xiamen Surgaid Medical Device Co., LTD | NGCS 100-1 | Sterile, ethylene oxide sterilized, disposable |
Suction and irrigation tube | Tonglu Hengfeng Medical Device Co., LTD | HF6518.035 | Sterile,dry heat sterilized, reusable |
Ultrasounic-harmonic scalpel | Chongqing Maikewei Medical Technology Co., LTD | QUHS36S | Sterile, ethylene oxide sterilized, disposable |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved